Bardoxolone Methyl and Kidney Function in CKD With Type 2 Diabetes

New England Journal of Medicine - United States
doi 10.1056/nejmoa1105351
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Massachusetts Medical Society

Related search

Cardiac and Renal Function in Patients With Type 2 Diabetes Who Have Chronic Kidney Disease: Potential Effects of Bardoxolone Methyl

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2012English

Effect of Bardoxolone Methyl on the Urine Albumin-To-Creatinine Ratio in Patients With Type 2 Diabetes and Stage 4 Chronic Kidney Disease.

Kidney International
Nephrology
2019English

New Pharmacological Strategies for Protecting Kidney Function in Type 2 Diabetes

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Metformin in Patients With Type 2 Diabetes and Kidney Disease

JAMA - Journal of the American Medical Association
Medicine
2014English

Kidney Biomarkers and Decline in eGFR in Patients With Type 2 Diabetes

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Dulaglutide Slows Kidney Disease in Type 2 Diabetes

The Lancet
Medicine
2020English

Kidney Function Decline in Patients With CKD and Untreated Hepatitis C Infection

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Lung Function in Type 1 and Type 2 Diabetes Mellitus

International Journal of Innovative Research in Medical Science
2019English

Facility-Level Variations in Kidney Disease Care Among Veterans With Diabetes and CKD

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy